The Physics of Aging: Why Slowing It Beats Chasing Reversal — Dr Peter Fedichev
Physicist and Gero CEO Dr Peter Fedichev argues that aging is an entropic, one-way process — a single emergent "thermodynamic biological age" that no known intervention reverses. His conclusion is optimistic rather than bleak: if the clock cannot run backwards, the realistic prize is slowing it, which could close the roughly 40-year gap between average and maximum human lifespan.
Overview
Dr Peter Fedichev, co-founder and CEO of Gero, brings a physicist's lens to aging research. He opens with the significance of GLP-1 drugs: for the first time, a single well-understood molecule visibly lowers the risk of multiple conditions at once, which he treats as a proof of concept for the long-held idea that one biology can move many diseases. From there he explains why physics is the right language for aging — biological age is an emergent, whole-organism property, much like a stock index emerges from thousands of separate companies.
He argues that the proliferation of different biological clocks (epigenetic, glycation, organ-specific) is a signal that none of them is fundamental, and that a single master age underlies them all. That master age, in his framing, is entropy: damage that accumulates in one direction only. He separates age-related change into reversible and irreversible layers, and maps three tiers of possible interventions — disease-by-disease drugs worth a few years, drugs that could bridge the average lifespan of about 80 toward the maximum of about 120, and a still-speculative tier that would push the maximum itself.
He is openly at odds with the reprogramming camp, noting that pushing regeneration hard in a living adult tends to generate tumours, and pointing instead to naked mole rats, which never accelerate their mortality in the first place. He also explains why dogs have become central to his work: they are long-lived mammals that age like us but three to five times faster, making them a practical proving ground. He closes with the human-scale reflections — physiological reserve, VO2 max, muscle mass, an engaged brain, and the badly underrated weight of social connection and self-respect.
Key quotes
5If you have too many ways to measure something, that is a symptom that what you're measuring is not fundamental.
You cannot revert time, but you can slow the way the time goes.
Yes, you can reset all the cells, but you will destroy the organism.
That's what I call the second law on your face.
It's almost never too late to increase your physiological reserve.
Key ideas
9GLP-1 as the field's proof of concept
A drug developed outside gerontology showed that one targeted molecule with a clear mechanism can lower the risk of several conditions at once. For Fedichev this validates the long-held premise that a single actionable biology sits underneath many diseases.
Biology enters tech-scale economics
The GLP-1 class now sells at roughly a hundred billion dollars a year, which he notes exceeds current AI revenues. That scale is what is pulling technology capital and talent into aging biology.
Aging as an emergent property
Biological age is not a property of any single organ but of the whole organism, the way a stock index emerges from many separate companies. Physics is the discipline built to describe exactly this kind of emergence.
One master biological age
Epigenetic, glycation and organ-specific clocks all give different numbers, which he reads as evidence that none is fundamental. He proposes a single master age underneath them, with the rest merely following it.
Reversible versus irreversible change
Some age-related changes can be undone, others cannot. The more irreversible damage accumulates, the higher the probability of further damage showing up as chronic disease.
Three tiers of intervention
Treating diseases one by one buys a few years. A second tier could bridge the average lifespan of around 80 toward the maximum of around 120. A third tier, which would raise the maximum itself, remains speculative.
Stay young rather than reset
Naked mole rats show manifestations of aging without accelerating mortality. Fedichev argues that never accelerating is a more tractable engineering goal than resetting an adult organism to zero.
Resilience as the readable signal
The older a person is, the longer recovery from any disruption takes, and near the limit of lifespan recovery time approaches infinity. That loss of resilience is measurable and tracks the same underlying variable as functional decline.
Many signals, one variable
Because master age is emergent, it can be read from proteomics, metabolomics, epigenetics, facial features or functional tests. The goal is to learn what all these signals have in common rather than to crown one assay.
Practical takeaways
7- 1
Judge claims by direction, not enthusiasm 15:10
When an intervention is described as reversing aging, ask whether it changes markers that move with age or the underlying clock. The distinction separates marketing language from mechanism.
- 2
Watch your recovery time 29:30
How long it takes to bounce back — after a hard session, a bad night, a minor illness — is one of the most informative signals of biological resilience available without a lab.
- 3
Build physiological reserve 43:50
Function tends to drift by roughly one percent a year across everything from cognition to muscle. Reserve built through regular training is what that drift eats into first.
- 4
Muscle mass and VO2 max as buffers 44:10
Fedichev singles out both as broad protectors. They are also among the few variables an individual can move meaningfully at almost any age.
- 5
Keep the brain loaded 44:20
Cognitive reserve behaves like physical reserve. Sustained mental demand is the practical way to keep building it.
- 6
Take social life seriously 44:40
Self-respect, feeling needed, and the quality of connection show up strongly in biobank statistics. He calls this the most underappreciated factor in longevity conversations.
- 7
Look for the biggest possible effect first 40:30
Before testing anything, his team asks what the maximum achievable effect would be if it worked. It is a useful filter for personal experiments too.
Topics & chapters
15The ultimate biotechnology
Fedichev opens with the question driving his company: if one GLP-1 drug was found opportunistically, how many more are waiting? And could one of them touch aging itself?
Why tech capital is entering biology
Fresh funding from technology investors reflects a broader convergence, where physics and machine learning are being pointed at the root causes of aging and chronic disease.
GLP-1 as proof of concept
A single targeted drug lowering risk across multiple conditions is presented as the demonstration gerontology had been waiting for, delivered from outside the field.
A physicist's definition of aging
Aging is described not as one process but as a byproduct of metabolism, accumulating with the irreversibility that physics recognises immediately.
Emergence and the index analogy
Biological age emerges from countless processes the way a market index emerges from many industries — a single number describing a whole system.
Too many clocks means none is fundamental
Different organs and different assays give different ages. Fedichev reads that fragmentation as a sign that a single master age lies beneath.
Reversible and irreversible layers
Chronic diseases are chronic for a reason. Irreversible entropic damage raises the probability of further damage, which surfaces as disease.
From 80 to 120: the tiers of drugs
Disease-by-disease drugs buy a few years; a second tier could close the roughly 40-year gap between average and maximum lifespan.
Naked mole rats versus reprogramming
Rather than resetting an aged organism, he points to a species that simply never accelerates its mortality, and warns about tumour risk from aggressive in-vivo rejuvenation.
Thermodynamic biological age
From dynamic organism state indicators to a thermodynamic age, built on the observation that recovery time lengthens until it becomes effectively infinite.
The evidence on maximum lifespan
Three centuries of demographic data show disease mortality falling and onset shifting later, but no sign that the maximum human lifespan itself has moved.
Measuring it, and why dogs matter
Consortium work on biological-age biomarkers is converging, and dogs — long-lived mammals aging three to five times faster than us — become the practical testing ground.
Reading one variable from many signals
Proteomics, metabolomics, epigenetics, facial features and functional measures are all windows onto the same underlying quantity if you know what to extract.
The pipeline and pharma partnerships
Better models of human health serve a dual strategy: novel disease targets for partners such as Chugai, and anti-aging targets developed in house.
What to do while we wait
Physiological reserve, muscle mass, VO2 max, an engaged brain, and the underrated weight of social connection and self-respect.